Our Episodes
Listen to our episodes, read our episode shownotes, and review our references all on your favorite podcast-streaming platforms:
Links to all of our episodes, the shownotes, and references can also be found below.
Thanks so much for tuning in; We are are so glad you are here.
Episode 050: #NephMadness Onconephrology - ICI-Associated AKI and Chemotherapy-Related Hypomagnesemia
Episode 050: #NephMadness Onconephrology - ICI-Associated AKI and Chemotherapy-Related Hypomagnesemia
The Fellow on Call is thrilled to partner with so many of our podcasting friends be a part of #NephMadness 2023 this year. In today’s episode, we welcome three incredible guests to our show, Dr. Matthew Abramson, Dr. Timothy Yau, and Dr. Scott Stockholm, to talk about the two very critical topics in hematology/oncology. The first is a discussion about immune checkpoint inhibitor-related AKIs. The second is a discussion about hypomagnesia in our patients. To learn more about NephMadness and to cast your votes, be sure to check out: https://ajkdblog.org/tag/nephmadness2023/. We’d love to see Onconephrology snag that #1 spot!
Episode 049: Myeloma Series, Pt.10- Multiple Myeloma Capstone
Episode 049: Myeloma Series, Pt.10- Multiple Myeloma Capstone
It’s been a long road, but incredibly educational journey, through our Myeloma Series. We finish off our series with a bang by sitting down with Multiple Myeloma Superstar, Dr. Manni Mohyuddin. In this episode, Dr. Mohyuddin takes us through his approach to complex decisions in the care of patients with myeloma, highlighting that myeloma treatment is an art in which we take imperfect data and try to make the best decisions for our patients. Trust us, folks, you do NOT want to miss this episode!
Episode 048: Myeloma Series, Pt.9- Transplant in Myeloma Capstone
Episode 048: Myeloma Series, Pt.9- Transplant in Myeloma Capstone
In episode 046, we discussed the fundamentals of transplant in the treatment of patients with multiple myeloma. This week, we sit down with two incredible hematologists who specialize in transplant to discuss the real-life decision-making that goes into evaluating each patient. We are so excited to welcome two special guests this week, Dr. Shonali Midha and Dr. Amar Kelkar, joining us from the Dana-Farber Cancer Institute in Boston!
Episode 047: Myeloma Series, Pt.8- Myeloma Maintenance Therapy
Episode 047: Myeloma Series, Pt. 8 – Myeloma Maintenance Therapies
We continue our myeloma series, transitioning our discussion from autologous stem cell transplant to maintenance therapy for myeloma.
Episode 046: Myeloma Series, Pt.7- Autologous Transplant in Multiple Myeloma
Episode 046: Myeloma Series, Pt. 7 – Autologous Transplant in Multiple Myeloma
In this continuation of our myeloma series, we discuss all the key principles and data surrounding autologous stem cell transplant in myeloma. We provide a succinct summary of key trials in this space that will give you a deep understanding of the field.
Episode 045: Myeloma Series, Pt.6- Myeloma Treatment in Transplant Ineligible Patients
Episode 045: Myeloma Series, Pt.6 - Myeloma Treatment in Transplant Ineligible Patients
In this episode, we start with a little bit of story time about the history of myeloma treatments and how we got to the present day. We then finish off the episode with how this information helped us treat transplant ineligible patients.
Episode 044: Myeloma Series, Pt.5 - Myeloma Treatment
Episode 044: Myeloma Series, Pt.5 - Myeloma Treatment
In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.
Episode 043: Myeloma Series, Pt.4 - Myeloma Pharmacology
Episode 043: Myeloma Series, Pt.4 - Myeloma Pharmacology
In this continuation of our myeloma series, we begin our discussion about treatment options for multiple myeloma, focusing first on pharmacology. We are so thrilled to have a special guest, Kathryn Maples, PharmD, BCOP who is a clinical pharmacy specialist in Multiple Myeloma at the Winship Cancer Institute of Emory Healthcare in Atlanta, Georgia!
Episode 042: Myeloma Series, Pt.3 - Intro to Multiple Myeloma
Episode 042: Myeloma Series, Pt.3 - Intro to Multiple Myeloma
In this continuation of our myeloma series, we discuss the progression of MGUS & smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment.
Episode 041: Myeloma Series, Pt.2 - Intro to MGUS and Smoldering Myeloma
Episode 041: Myeloma Series, Pt.2 - Intro to MGUS and Smoldering Myeloma
In today’s episode, we continue our myeloma series, this time we’ll delve deeper into the spectrum of plasma cell dyscrasias, including defining MGUS, discussing surveillance of MGUS, defining smoldering myeloma (SM). We are slowly inching our discussion towards the diagnosis of Multiple myeloma (MM)!
Episode 040: Myeloma Series, Pt.1 - Intro to Testing and MGUS
Episode 040: Myeloma Series, Pt.1 - Intro to Testing and MGUS
In the first episode in our highly-anticipated multiple myeloma series, we begin our discussion about introduction to testing/workup for plasma cell dyscrasias and having our initial discussion about monoclonal gammopathy of undetermined significance (MGUS).
Episode 039: Hemophilia 101, Pt 4
Episode 039: Hemophilia 101, Pt 4
In this episode, we discuss the acute management of the bleeding patient with acquired hemophilia.
Episode 038: Hemophilia 101, Pt 3
Episode 038: Hemophilia 101, Pt 3
In this episode, we discuss the acute management of the bleeding patient with hemophilia including factor replacement.
Episode 037: Hemophilia 101, Pt 2
Episode 037: Hemophilia 101, Pt. 2
In this episode, we discuss the fundamentals and approaches to chronic management and treatment for patients with known inherited hemophilia.
Episode 036: Hemophilia 101, Pt 1
Episode 036: Hemophilia 101, Pt. 1
In this episode, we break down the initial approach to the evaluation of a patient with a suspected bleeding disorder, particularly in regards to hemophilia, including standardized bleeding assessment tools, the basics of the coagulation cascade, and mixing studies.
Episode 035: Lung Cancer Series, Pt. 12: NSCLC Capstone with Dr. Jack West (Con’t)
Episode 035: Lung Cancer Series, Pt. 12: NSCLC Capstone with Dr. Jack West (Con’t)
Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. This week, we finish out our NSCLC series with our interview Dr. Jack West of City of Hope.
Episode 034: Lung Cancer Series, Pt. 11: NSCLC Capstone with Dr. Jack West
Episode 034: Lung Cancer Series, Pt. 11: NSCLC Capstone with Dr. Jack West
Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. This week, we begin to round out our NSCLC series with the first of two episodes where we interview Dr. Jack West of City of Hope.
Episode 033: Lung Cancer Series, Pt. 10: Metastatic NSCLC with driver mutations
Episode 033: Lung Cancer Series, Pt. 10: Metastatic NSCLC with driver mutations
Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. This week, we continue our discussion on metastatic non-small cell lung cancer, focusing on NSCLC with driver mutations.
Episode 032: Lung Cancer Series, Pt. 9: Metastatic NSCLC without driver mutations
Episode 032: Lung Cancer Series, Pt. 9: Metastatic NSCLC without driver mutations
Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. This week, we start our discussion on metastatic non-small cell lung cancer, focusing on NSCLC without driver mutations.
Episode 031: Lung Cancer Series, Pt. 8: Surgical considerations in early stage NSCLC
Episode 031: Lung Cancer Series, Pt. 8: Surgical considerations in early stage NSCLC
Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. This week, we sit down with Thoracic Surgeon, Dr. Jane Yanagawa to discuss surgical considerations in treatment of NSCLC.